Viewing Study NCT01719861


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2025-12-28 @ 1:30 AM
Study NCT ID: NCT01719861
Status: TERMINATED
Last Update Posted: 2017-04-17
First Post: 2012-10-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
Sponsor: Joel Neal
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Cancer (SCLC) View
None Neuroendocrine Tumors View
Keywords: